**G2: PASS — accept candidate `96a4845848ee8cfd5b77dbf2ad4a5d8f0215731c`**, reviewed against Phase 1 `3541fc0d8749bda97c5acbe4ba632dbf2b37da3d`.

No critical, high, or medium actionable findings.

- Accepted role (`85c8d30`), perturbation (`1ee5555`), and cache (`b176bb5`) source/tests reached this candidate unchanged.
- Fresh P2 regression run: **124 passed**.
- Independent synthetic integration probe: **256 passed**, covering sampler → realization → authorized extraction → cache round-trip, all 15 nonempty masks, both fusion trees, and four training strata.
- Reviewed committed evidence for 164 tests, Ruff, compilation, and CLI help.
- Role/grouping/lock checks, held-out stress restrictions, parent/child reuse, target regeneration, provenance mutation rejection, and private artifact staging protections remain intact.
- Legacy source/tests are unchanged; synthetic score/prediction compatibility checks pass. Worktree remains clean.

Nonblocking check note: the base-to-candidate diff reports four Markdown trailing-whitespace lines in the archived first cache review. Source/test diff checks pass.

Real patient mapping, locked-identity overlap, content audits, and actual pretrained parity remain unverified. Full-state hashing cost remains disclosed and unmeasured. This acceptance establishes generic software readiness only; it establishes no scientific result or real-data readiness.

Final phase commit, publication, and release remain with the orchestrator.